Call Options Transactions Made in Q2 2023 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q2 2023. The information is specifically focused on institutions that hold call options of Adaptimmune Therapeutics PLC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-3.83K- 38.25% |
$3.44K - $5.78K
|
6.18K
$3.71K
|